Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment to "Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation" Haematologica. 2012;97(12):1845-9.

Literature DB >> 23300181

Comment to "Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation" Haematologica. 2012;97(12):1845-9.

Andreas Holbro, Martine Jotterand, Jakob R Passweg, Andreas Buser, André Tichelli, Alicia Rovó.

Abstract

Entities: Species

Mesh：

Year: 2013 PMID： 23300181 PMCID： PMC3660003 DOI： 10.3324/haematol.2012.082875

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

9 in total

1. Selection of patients for bone marrow transplantation in severe aplastic anemia.

Authors: B M Camitta; J M Rappeport; R Parkman; D G Nathan
Journal: Blood Date: 1975-03 Impact factor: 22.113

Review 2. Bone marrow cytogenetic abnormalities of aplastic anemia.

Authors: Y K Keung; M J Pettenati; J M Cruz; B L Powell; R D Woodruff; D H Buss
Journal: Am J Hematol Date: 2001-03 Impact factor: 10.047

3. Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation.

Authors: Kohei Hosokawa; Takamasa Katagiri; Naomi Sugimori; Ken Ishiyama; Yumi Sasaki; Yu Seiki; Aiko Sato-Otsubo; Masashi Sanada; Seishi Ogawa; Shinji Nakao
Journal: Haematologica Date: 2012-06-11 Impact factor: 9.941

Review 4. Diagnosis of acquired aplastic anemia.

Authors: A Rovó; A Tichelli; C Dufour
Journal: Bone Marrow Transplant Date: 2012-11-19 Impact factor: 5.483

5. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

Authors: Jaroslaw P Maciejewski; Antonio Risitano; Elaine M Sloand; Olga Nunez; Neal S Young
Journal: Blood Date: 2002-05-01 Impact factor: 22.113

6. Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy.

Authors: Ken Ishiyama; Masamitsu Karasawa; Shuichi Miyawaki; Yasunori Ueda; Masaaki Noda; Atsushi Wakita; Masakazu Sawanobori; Hirokazu Nagai; Shinji Nakao
Journal: Br J Haematol Date: 2002-06 Impact factor: 6.998

7. Cytogenetic abnormalities in patients with severe aplastic anemia.

Authors: N Mikhailova; M Sessarego; G Fugazza; A Caimo; S De Filippi; M T van Lint; S Bregante; A Valeriani; N Mordini; T Lamparelli; F Gualandi; D Occhini; A Bacigalupo
Journal: Haematologica Date: 1996 Sep-Oct Impact factor: 9.941

8. Spontaneous clinical and cytogenetic remission of aplastic anemia in a patient with del(13q).

Authors: Takashi Saitoh; Minoru Saiki; Takao Kumagai; Yoshimasa Kura; Umihiko Sawada; Takashi Horie
Journal: Cancer Genet Cytogenet Date: 2002-07-15

9. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?

Authors: David P Steensma; Gordon W Dewald; Janice M Hodnefield; Ayalew Tefferi; Curtis A Hanson
Journal: Leuk Res Date: 2003-03 Impact factor: 3.156

9 in total

6 in total

1. Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?

Authors: S Nakao; R P Gale
Journal: Leukemia Date: 2016-09-02 Impact factor: 11.528

Review 6. When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis.

Authors: Nicolas Bonadies; Alicia Rovó; Naomi Porret; Ulrike Bacher
Journal: J Clin Med Date: 2021-03-02 Impact factor: 4.241